跳至主要内容
临床试验/NCT02549105
NCT02549105Unknown4 期

A Comparison Between Lidocaine-Prilocaine Cream (EMLA) Application And Wound Infiltration With Lidocaine For Post Caesarean Section Pain Relief : A Randomized Controlled Trial

Ain Shams Maternity Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2014年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
80
试验地点
1
主要终点
TIME TO THE FIRST DOSE OF RESCUE ANALGESIC IN THE FIRST 6 HOURS

研究概览

简要总结

A Comparison Between Lidocaine-Prilocaine Cream (EMLA) Application And wound Infiltration with Lidocaine For Post Caesarean Section Pain Relief : A Randomized Controlled Trial.

详细描述

The purpose of this study is to compare the effectiveness of topically applied lidocaine-prilocaine (EMLA) cream with local anesthetic (lidocaine) infiltration on post-cesarean section pain.

Research Question:

Is lidocaine-prilocaine (EMLA) cream application effective as compared to local anesthetic (lidocaine) infiltration on post-caesarean section pain?

Research Hypothesis:

Lidocaine-prilocaine (EMLA) cream application is effective in post_caesarean section pain as compared to local anesthetic (lidocaine) infiltration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Age between 18 and 40 years.
  • Patient American Society of Anesthesiologists physical status І or П.
  • Gestational age of pregnancy of 37w or more.
  • Patient have no previous section or have 1or 2 previous sections.
  • Patient having no medical disorders.
  • Patient with no obstetrical complications.

排除标准

  • age below18 or above
  • Women American Society of Anesthesiologists physical status ш or more.
  • Women having more than 2 previous cesarean section.
  • Women receive cardio vascular drugs or having history of cardio vascular disease.
  • Women with Medical disorders with pregnancy as diabetes milletus.
  • Women having obstetrical complications as antepartum hemorrhage, pre-eclampsia or eclampsia.
  • Women having metabolic, hormonal, respiratory, renal and hepatic disease.
  • Women with any severe allergic condition or severe asthma.
  • Mental condition rendering the patients unable to understand the nature, scope and possible consequences of the study.

研究组 & 干预措施

EMLA CREAM

Active Comparator

EMLA CREAM 5 mg TOPICAL APPLICATION FOR CS WOUND AND ASSESSMENT FOR POST OPERATIVE PAIN IN FIRST 6 HOURS

干预措施: EMLA CREAM 5 mg (Drug)

LIDOCAINE INFILTERATION

Active Comparator

LIDOCAINE 1 % 20 ml INFILTERATION FOR WOUND AND ASSESSMENT OF POST OPERATIVE PAIN IN FIRST 6 HOURS

干预措施: LIDOCAINE 1 % (Drug)

结局指标

主要结局

TIME TO THE FIRST DOSE OF RESCUE ANALGESIC IN THE FIRST 6 HOURS

时间窗: 6 H

次要结局

  • POSTOPERATIVE PAIN ACCORDING TO VAS(24 H)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

HANY AYAD IBRAHIM

RESIDENT DOCTOR

Ain Shams Maternity Hospital

研究点 (1)

Loading locations...

相似试验

Lidocaine-Prilocaine Cream (EMLA) Topical... | 临床试验